Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $8.97 USD
Change Today +0.05 / 0.56%
Volume 3.8M
ARIA On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Edward M. Fitzgerald

Chief Financial Officer, Executive Vice President and Treasurer, Ariad Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

59$1,356,416
As of Fiscal Year 2014

Background*

Mr. Edward M. Fitzgerald has been the Chief Financial Officer and Treasurer of ARIAD Pharmaceuticals, Inc. since May 2002 and has been its Executive Vice President since June 2010. Mr. Fitzgerald served as Senior Vice President of Finance & Corporate Operations and Principal Accounting Officer at Ariad Pharmaceuticals Inc. From 1998 to April 2002, he served as Senior Vice President, Chief Financial Officer and Secretary of Twin Butte Energy Ltd. (formerly AltaRex Corp.), ...

Read Full Background

Corporate Headquarters*

26 Landsdowne Street
Cambridge, Massachusetts 02139

United States

Phone: 617-494-0400
Fax: 617-494-8144

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
Babson College
MBA
Babson College

Other Affiliations*

Annual Compensation*

Salary$466,000
Bonus$210,000
Total Annual Compensation$676,000

Stock Options*

Restricted Stock Awards$650,320
All Other Compensation$30,096
Exercised Options50,000
Exercised Options Value$49,336
Exercisable Options283,667
Exercisable Options Value$382,800
Unexercisable Options60,333
Total Value of Options$432,136
Total Number of Options394,000

Total Compensation*

Total Annual Cash Compensation$706,096
Total Short Term Compensation$676,000
Other Long Term Compensation$680,416
Total Calculated Compensation$1,356,416
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARIA:US $8.97 USD +0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Arena Pharmaceuticals, Inc.
$746.8K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma Inc.
$548.8K
Werner Lanthaler MBA,MPAChief Executive Officer and Member of Management Board
Evotec AG
€459.0K
Aijaz Tobaccowalla Managing Director, Director, Member of Nomination and Remuneration Committee and Member of Board Administrative Committee
Pfizer Limited
30.3M
Michael L. Babich Chief Executive Officer, President and Director
INSYS Therapeutics, Inc.
$889.2K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARIAD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.